Patents by Inventor Lindsay Lovasco

Lindsay Lovasco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same
    Patent number: 7115407
    Abstract: In accordance with the present invention, there is provided a DNA (deoxyribonucleic acid) fragment which encodes the MmeI type II restriction endonuclease enzyme. This one polypeptide possesses two related enzymatic functions; namely an endonuclease activity which recognizes the DNA sequence 5?-TCC(Pu)AC-3? and cleaves as indicated by the arrows: 5?-TCCRAC(N20)?-3? 3?-AGGYTG(N18)?-5? and a second enzymatic activity that recognizes the same DNA sequence, 5?-TCC(Pu)AC-3?, but modifies this sequence by the addition of a methyl group to prevent cleavage by the MmeI endonuclease activity.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: October 3, 2006
    Assignee: New England BioLabs, Inc.
    Inventors: Richard D. Morgan, Tanya Bhatia, Theodore Davis, Lindsay Lovasco
  • Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same
    Publication number: 20040091911
    Abstract: In accordance with the present invention, there is provided a DNA (deoxyribonucleic acid) fragment which encodes the MmeI type II restriction endonuclease enzyme.
    Type: Application
    Filed: July 10, 2003
    Publication date: May 13, 2004
    Inventors: Richard D. Morgan, Tanya Bhatia, Theodore Davis, Lindsay Lovasco